Overview

This interdisciplinary textbook encompasses all clinically relevant aspects of the disease and is designed to be as user-friendly as possible in order to meet the needs of the busy practitioner. To this end, the informative text is complemented by helpful boxed sections that present essential 'take home' points and illustrative patient-oriented cases. Original high-quality images, some in color, are included whenever necessary to simplify particularly complex material. The authors are an international group of acknowledged experts in kidney cancer epidemiology, molecular biology, pathology, diagnosis, clinical features, staging, prognostic and predictive factors, surgery, systemic therapy, and emerging investigational approaches, among others. This clinically oriented volume will be of great interest to clinicians, researchers, residents, and fellows, as well as to students and knowledgeable lay people.

Full Product Details

Author:   Primo N. Lara ,  Eric Jonasch
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2012
Dimensions:   Width: 19.30cm , Height: 1.80cm , Length: 26.00cm
Weight:   0.907kg
ISBN:  

9783642218576

ISBN 10:   3642218571
Pages:   301
Publication Date:   25 January 2012
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Awaiting stock  
The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you.

Table of Contents

Epidemiology and biology: Rencal cell cancer (RCC) epidemiology. Pathology of RCC. Molecular biology of RCC. Prognostic and predictive biomarkers.- Clinical considerations: Clinical presentation and staging.- Surgical and local control modalities: Surgical approaches to early stage RCC. Palliative debulking nephrectomy in advanced stage RCC. Metastasectomy. Energy ablative techniques in RCC. Radiation therapy in RCC.- Systemic therapy considerations: Cytokines and other immune therapies in RCC. Anti-VEGF therapy in RCC. The role of mTOR inhibitors and PI3K pathway blockade in RCC. Sequential versus combination strategies. Presurgical therapy. Toxicity management for patients on targeted therapy. Emerging agents in RCC.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions